http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0211523-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1755eede76ea7e719a3e0d2843cd793 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 1988-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5588bf155c2a4501c2a1351071cea00f |
| publicationDate | 1990-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0211523-A |
| titleOfInvention | Immunoadsorbent for remedy of malignant tumor, etc., and remedying method using the same agent |
| abstract | PURPOSE: To obtain a composition useful for the remedy of malignant tumor and autoimmune diseases by preparing a specific polypeptide fragment having an Fc bonding region linkable to the Fc region of an immunoglobulin and producible by a gene recombination technique and supporting the obtained polypeptide fragment on an inert carrier. n CONSTITUTION: A polypeptide produced by adding cysteine to the N-terminal or C-terminal of a polypeptide fragment of protein A originated from Staphylococcus aureus Cowan I strain and constituting an Fc bonding region linkable to the Fc region of an immunoglobulin is produced by a gene recombination technique and the obtained polypeptide is supported on an inert carrier to obtain the objective immunoadsorbent. The immobilization of the polypeptide on a carrier can be carried out under mild and easy condition by the addition of cysteine. The plasma, serum or whole blood extracted from a living body is made to contact with the immunoadsorbent and the treated plasma, etc., is introduced into the same kind of a living body to effect the remedy of malignant tumor and autoimmune diseases. n COPYRIGHT: (C)1990,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168189-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010031050-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008513457-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005527581-A |
| priorityDate | 1988-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715 |
Total number of triples: 22.